These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1120 related items for PubMed ID: 26624824

  • 1. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
    Libman IM, Miller KM, DiMeglio LA, Bethin KE, Katz ML, Shah A, Simmons JH, Haller MJ, Raman S, Tamborlane WV, Coffey JK, Saenz AM, Beck RW, Nadeau KJ, T1D Exchange Clinic Network Metformin RCT Study Group.
    JAMA; 2015 Dec 01; 314(21):2241-50. PubMed ID: 26624824
    [Abstract] [Full Text] [Related]

  • 2. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    Dahl D, Onishi Y, Norwood P, Huh R, Bray R, Patel H, Rodríguez Á.
    JAMA; 2022 Feb 08; 327(6):534-545. PubMed ID: 35133415
    [Abstract] [Full Text] [Related]

  • 3. Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial.
    Lingvay I, Pérez Manghi F, García-Hernández P, Norwood P, Lehmann L, Tarp-Johansen MJ, Buse JB, DUAL V Investigators.
    JAMA; 2016 Mar 01; 315(9):898-907. PubMed ID: 26934259
    [Abstract] [Full Text] [Related]

  • 4. Liraglutide in Children and Adolescents with Type 2 Diabetes.
    Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, Jalaludin MY, Kovarenko M, Libman I, Lynch JL, Rao P, Shehadeh N, Turan S, Weghuber D, Barrett T, Ellipse Trial Investigators.
    N Engl J Med; 2019 Aug 15; 381(7):637-646. PubMed ID: 31034184
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
    Dejgaard TF, Frandsen CS, Hansen TS, Almdal T, Urhammer S, Pedersen-Bjergaard U, Jensen T, Jensen AK, Holst JJ, Tarnow L, Knop FK, Madsbad S, Andersen HU.
    Lancet Diabetes Endocrinol; 2016 Mar 15; 4(3):221-232. PubMed ID: 26656289
    [Abstract] [Full Text] [Related]

  • 6. Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy.
    Barnett AH, Charbonnel B, Li J, Donovan M, Fleming D, Iqbal N.
    Clin Drug Investig; 2013 Oct 15; 33(10):707-17. PubMed ID: 23949898
    [Abstract] [Full Text] [Related]

  • 7. Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study.
    Nadeau KJ, Chow K, Alam S, Lindquist K, Campbell S, McFann K, Klingensmith G, Walravens P.
    Pediatr Diabetes; 2015 May 15; 16(3):196-203. PubMed ID: 24698216
    [Abstract] [Full Text] [Related]

  • 8. A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes.
    Nwosu BU, Maranda L, Cullen K, Greenman L, Fleshman J, McShea N, Barton BA, Lee MM.
    PLoS One; 2015 May 15; 10(9):e0137525. PubMed ID: 26367281
    [Abstract] [Full Text] [Related]

  • 9. Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    Davies M, Pieber TR, Hartoft-Nielsen ML, Hansen OKH, Jabbour S, Rosenstock J.
    JAMA; 2017 Oct 17; 318(15):1460-1470. PubMed ID: 29049653
    [Abstract] [Full Text] [Related]

  • 10. Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial.
    Hamilton J, Cummings E, Zdravkovic V, Finegood D, Daneman D.
    Diabetes Care; 2003 Jan 17; 26(1):138-43. PubMed ID: 12502670
    [Abstract] [Full Text] [Related]

  • 11. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, Kollman C, Kruger D, McGill JB, Polonsky W, Toschi E, Wolpert H, Price D, DIAMOND Study Group.
    JAMA; 2017 Jan 24; 317(4):371-378. PubMed ID: 28118453
    [Abstract] [Full Text] [Related]

  • 12. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM, Kanapka LG, Beck RW, Bergamo K, Clements MA, Criego A, DeSalvo DJ, Goland R, Hood K, Liljenquist D, Messer LH, Monzavi R, Mouse TJ, Prahalad P, Sherr J, Simmons JH, Wadwa RP, Weinstock RS, Willi SM, Miller KM, CGM Intervention in Teens and Young Adults with T1D (CITY) Study Group, CDE10.
    JAMA; 2020 Jun 16; 323(23):2388-2396. PubMed ID: 32543683
    [Abstract] [Full Text] [Related]

  • 13. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial.
    Feig DS, Donovan LE, Zinman B, Sanchez JJ, Asztalos E, Ryan EA, Fantus IG, Hutton E, Armson AB, Lipscombe LL, Simmons D, Barrett JFR, Karanicolas PJ, Tobin S, McIntyre HD, Tian SY, Tomlinson G, Murphy KE, MiTy Collaborative Group.
    Lancet Diabetes Endocrinol; 2020 Oct 16; 8(10):834-844. PubMed ID: 32946820
    [Abstract] [Full Text] [Related]

  • 14. Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial.
    Rosenstock J, Allison D, Birkenfeld AL, Blicher TM, Deenadayalan S, Jacobsen JB, Serusclat P, Violante R, Watada H, Davies M, PIONEER 3 Investigators.
    JAMA; 2019 Apr 16; 321(15):1466-1480. PubMed ID: 30903796
    [Abstract] [Full Text] [Related]

  • 15. Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapy.
    Herrmann K, Frias JP, Edelman SV, Lutz K, Shan K, Chen S, Maggs D, Kolterman OG.
    Postgrad Med; 2013 May 16; 125(3):136-44. PubMed ID: 23748514
    [Abstract] [Full Text] [Related]

  • 16. Effects of Metformin Added to Insulin in Adolescents with Type 1 Diabetes: An Exploratory Crossover Randomized Trial.
    Yang D, Yan J, Deng H, Yang X, Luo S, Zheng X, Lv J, Liang W, Hong M, Wu Z, Yao B, Weng J, Xu W.
    J Diabetes Res; 2020 May 16; 2020():7419345. PubMed ID: 33457425
    [Abstract] [Full Text] [Related]

  • 17. Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial.
    Bailey CJ, Gross JL, Hennicken D, Iqbal N, Mansfield TA, List JF.
    BMC Med; 2013 Feb 20; 11():43. PubMed ID: 23425012
    [Abstract] [Full Text] [Related]

  • 18. Effect of Metformin on Vascular Function in Children With Type 1 Diabetes: A 12-Month Randomized Controlled Trial.
    Anderson JJA, Couper JJ, Giles LC, Leggett CE, Gent R, Coppin B, Peña AS.
    J Clin Endocrinol Metab; 2017 Dec 01; 102(12):4448-4456. PubMed ID: 29040598
    [Abstract] [Full Text] [Related]

  • 19. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, Schwarz E, Ólafsdóttir AF, Frid A, Wedel H, Ahlén E, Nyström T, Hellman J.
    JAMA; 2017 Jan 24; 317(4):379-387. PubMed ID: 28118454
    [Abstract] [Full Text] [Related]

  • 20. Benefits of metformin add-on insulin therapy (MAIT) for HbA1c and lipid profile in adolescents with type 1 diabetes mellitus: preliminary report from a double-blinded, placebo-controlled, randomized clinical trial.
    Sheikhy A, Eydian Z, Fallahzadeh A, Shakiba M, Hajipour M, Alaei M, Mosallanejad A, Saneifard H.
    J Pediatr Endocrinol Metab; 2022 Apr 26; 35(4):505-510. PubMed ID: 35249270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.